Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1

Archives of Neurology

Volumn 58, Issue 8, 2001, Pages 1281-1286

  Von Giesen, Hans Jürgen ^a   Wittsack, Hans Jörg ^a   Wenserski, Frank ^a   Köller, Hubertus ^a   Hefter, Harald ^a   Arendt, Gabriele ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BASAL GANGLION; BRAIN METABOLISM; CAUSE OF DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLITE; MOTOR DYSFUNCTION; NERVE CELL LESION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMOTOR PERFORMANCE; SERODIAGNOSIS;

EID: 0034881619     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.8.1281     Document Type: Article

References (39)

1. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection
2. Motor analysis predicts progression in HIV-associated brain disease
3. Psychomotor slowing in HIV infection: A predictor of dementia, AIDS and death
4. Proton MR spectroscopy in inflammatory and infectious brain disorders
5. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex
6. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
7. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients
8. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells
9. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: Electrophysiologic and positron emission tomography findings
10. HIV dementia: The role of the basal ganglia and dopaminergic systems
11. HAART is neuroprophylactic in HIV-1 infection
12. Improvement of motor performance of HIV-positive patients under AZT therapy
13. Neurological outcomes in late HIV infection: Adverse impact of neurological impairment on survival and protective effect of antiviral therapy
14. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men: Multicenter AIDS Cohort Study (MACS)
15. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment
16. Unified Parkinson's disease rating scale
17. HIV Dementia Scale: A rapid screening test
18. Stimulated echo imaging
19. 1H magnetic resonance spectra
20. 31p NMR signals using the variable projection method and prior knowledge
21. 1H spectroscopic imaging data sets
22. Absolute metabolite quantification by in vivo NMR spectroscopy, V: Multicentre quantitative data analysis trial on the overlapping background problem
23. 31p NMR spectra
24. Quality assessment in in vivo NMR spectroscopy, VI: Multicentre quantification of MRS test signals
25. Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit
26. HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers
27. AIDS dementia complex: Evaluation with proton MR spectroscopic imaging
28. HIV-related metabolic abnormalities in the brain: Depiction with proton MR spectroscopy with short echo times
29. 1H magnetic resonance spectroscopic imaging
30. Deep gray matter structures in HIV infection: A proton MR spectroscopic study
31. Metabolic characterization of AIDS dementia complex by spectroscopic imaging
32. Proton spectroscopy of the brain in HIV infection: Correlation with clinical, immunologic, and MR imaging findings
33. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study
34. 1H MR spectroscopy of the brain in HIV-1-seropositive subjects: Evidence for diffuse metabolic abnormalities
35. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
36. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection: Neuroradiological, neurophysiological, neuroimmunological, and virological correlates
37. HIV dementia and the basal ganglia
38. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy